Ivermectin is currently used for about
23% of the world's population.
Countries where COVID-19 mortality is close to zero may not have incentive to
adopt treatments. When excluding these countries, ivermectin adoption is about
31%. We excluded countries where the
cumulative mortality over the preceding month was less than 1 in 1 million,
according to the data at https://ourworldindata.org/
). For the
estimated population coverage, isolated use, some regions, mixed usage, and
many regions use a factor of 0.05, 0.25, 0.5, and 0.75 respectively. Please
send us corrections/updates with the form at the bottom of the page.